Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update

Sensus Healthcare, Inc. (NASDAQ:SRTS) saw a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 486,100 shares, a decrease of 18.1% from the November 15th total of 593,700 shares. Approximately 3.7% of the shares of the company are sold short. Based on an average daily volume of 161,300 shares, the short-interest ratio is presently 3.0 days.

Analyst Upgrades and Downgrades

A number of analysts have commented on SRTS shares. Maxim Group upped their price target on Sensus Healthcare from $12.00 to $14.00 and gave the stock a “buy” rating in a research report on Friday, November 15th. HC Wainwright lifted their target price on Sensus Healthcare from $10.00 to $11.00 and gave the company a “buy” rating in a research note on Monday, November 18th.

Hedge Funds Weigh In On Sensus Healthcare

A number of large investors have recently bought and sold shares of the business. Truvestments Capital LLC purchased a new stake in Sensus Healthcare in the 3rd quarter valued at about $32,000. Chapin Davis Inc. bought a new stake in Sensus Healthcare during the 2nd quarter valued at $53,000. Geode Capital Management LLC raised its holdings in shares of Sensus Healthcare by 8.5% in the third quarter. Geode Capital Management LLC now owns 146,404 shares of the company’s stock valued at $849,000 after acquiring an additional 11,525 shares in the last quarter. Sachetta LLC increased its position in Sensus Healthcare by 12.9% during the 2nd quarter. Sachetta LLC now owns 118,354 shares of the company’s stock valued at $631,000 after purchasing an additional 13,544 shares during the period. Finally, XTX Topco Ltd boosted its position in Sensus Healthcare by 76.0% during the 3rd quarter. XTX Topco Ltd now owns 31,530 shares of the company’s stock valued at $183,000 after acquiring an additional 13,619 shares in the last quarter. Hedge funds and other institutional investors own 25.30% of the company’s stock.

Sensus Healthcare Price Performance

Shares of SRTS traded down $0.33 during midday trading on Friday, hitting $8.16. The stock had a trading volume of 220,473 shares, compared to its average volume of 270,814. Sensus Healthcare has a 1 year low of $2.14 and a 1 year high of $9.33. The firm has a market cap of $133.74 million, a PE ratio of 14.32 and a beta of 1.16. The stock’s 50 day moving average is $7.46 and its 200 day moving average is $6.45.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.